Reliability of antibody tests for COVID-19 diagnosis

Author:

COPLU Nilay1ORCID,KILINC Cetin2ORCID,GOZALAN Aysegul3ORCID,CALISIR Busra2ORCID,SONMEZ Cemile4ORCID,GUL Mustafa Muhammet5ORCID,AYGUN AHLATCIOGLU Zeynep5ORCID

Affiliation:

1. Ankara City Hospital

2. Kastamonu Training and Research Hospital

3. ALANYA ALAADDIN KEYKUBAT UNIVERSITY

4. Ministry of Health

5. Kastamonu Training and Research Horpital

Abstract

Objective: The reverse transcription–polymerase chain reaction test (RT-PCR) is the gold standard for the diagnosis of coronavirus disease 2019 (COVID-19), and antibody tests are useful as supplemental tools for diagnosis, for measuring the population’s immunity levels, and for checking infection in asymptomatic contacts. This study aimed to evaluate the reliability of five commercial antibody detection test kits. Materials and Methods: The reliability of the Colloidal Gold COVID-19 IgG/IgM Rapid Test Kit, Antibody Rapid Test Hotgen, Beijing Hotgen Biotech Co., Ltd., China), Abbott Chemiluminescent Microparticle Immunoassay (Illinois, USA), Roche Electrochemiluminescence Immunoassay (Roche Diagnostics, Switzerland), Siemens Chemiluminescence (Munich, Germany), and Euroimmun ELISA (Lübeck, Germany) for COVID-19 diagnosis was studied. The antibody-negative group included 50 sera from 2018, and the antibody-positive group included 98 patients with positive RT-PCR results from whom blood samples had been collected 3–9 weeks after hospital discharge. Statistical analysis was performed using SPSS version 23.0 (IBM Corporation, Armonk, NY, USA). The antibody tests’ validity and intra-assay reproducibility were examined, and the Cohen’s kappa coefficients were obtained. The disease prevalence was pegged at 10%. Results: The antibody tests’ sensitivity (69.12–72.46%) and positive predictive values (42.44–100.0%) were low, and their specificity (89.58–100%) and negative predictive values (96.31–97.03%) were high. Their accuracy rates varied from 87.54% to 97.25%, and their intra-assay coefficients of variation varied from 1% to 10%. Conclusion: The agreement between the results of the antibody detection test kits was higher when the kits were classified according to the targeted antigens. The time of blood sample collection, targeted antigens, and antibody types affected the results. Serological tests were found to be useful, and the commercial kits were found to be largely reliable, although, some parameters need to be improved.

Publisher

Marmara University

Reference23 articles.

1. Long OX, Liu, BZ, Deng HJ. et al. Antibody responses to SARSCoV- 2 in patients with COVID-19. Nat Med 2020;26:845-8. doi.org/10.1038/s41591.020.0897-1

2. Yongchen Z, Shen H, Wang X , et.al. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Emerg Microbes Infect 2020; 9: 833-6. doi: 10.1080/22221.751.2020.1756699

3. Tehrani ZR, Saadat S, Saleh E, et.al. Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays. 2020, Plos One 2020. doi.org/10.1371/journal.pone.0237828

4. Rashid Z Z, Othman S N, Abdul Samat M N, Ali U K, Wong K K. Diagnostic performance of COVID-19 serology assays. COVID-19 serology. Malaysian J Pathol 2020; 42: 13-21.

5. Brochot E, Demey B, Touzé A, et.al. Anti-spike, antinucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic individuals. Front Microbiol 2020. doi.org/10.3389/fmicb.2020.584251

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3